Total raised: $38.54M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.07.2024 | Series A | $38.54M | - |
Mentions in press and media 3
| Date | Title | Description |
| 18.07.2024 | Renalys Pharma Closes ¥6.0Bn Series A Financing | Renalys Pharma, a Tokyo, Japan-based late-stage clinical biopharmaceutical company, raised a ¥6.0Bn in Series A funding. The round was led by Catalys Pacific and SR One, with participation from JPS Growth Investment Limited Partnership, Sum... |
| 17.07.2024 | Renalys Pharma Closes ¥6.0Bn Series A Financing to Advance Kidney Disease Treatments Across Asia | Financing Round Co-led by Catalys Pacific and SR One, Investment to Drive the Development of Sparsentan for IgA Nephropathy in Japan and Other Asian Countries TOKYO, July 17, 2024 /PRNewswire/ -- Renalys Pharma, Inc., a late-stage clinical ... |
| - | Renalys Pharma | “Renalys” |